## IRM: Iron Mountain Incorporated (Del - XLRE: Real Estate

### Executive Summary

VALUE thesis: PEG 1.08 indicates fundamental undervaluation. Quality metrics strong (ROE 225%).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($72.56)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 1, Bearish: 1)

**1. Iron Mountain (IRM) Gets a Buy from Wells Fargo**
- Source: The Globe and Mail | 20251217T122706 | Bullish | Relevance: 100%
- Wells Fargo analyst Eric Luebchow maintained a Buy rating on Iron Mountain (IRM) with a price target of $125.00. This rating follows recent financial results where Iron Mountain reported a quarterly revenue of $1.75 billion and a net profit of $84.29 million. The company has also received a Buy rating from Barclays, though another analyst reiterated a Hold rating.

**2. Iron Mountain Incorporated (IRM) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates**
- Source: CBS 17 | 20251217T020910 | Bearish | Relevance: 100%
- Levi & Korsinsky has initiated an investigation into Iron Mountain Incorporated (NYSE: IRM) following allegations of federal securities law violations. A report by Gotham City Research claims Iron Mountain understates leverage, inflates adjusted EBITDA, and uses aggressive pricing tactics. After this report, the company's shares dropped by over 5%.

**3. Wells Fargo Sticks to Their Buy Rating for Equinix (EQIX)**
- Source: The Globe and Mail | 20251217T120822 | Somewhat-Bullish | Relevance: 65%
- Wells Fargo analyst Eric Luebchow has maintained a Buy rating on Equinix (EQIX) with a price target of $925.00, citing the company's strong financial performance with recent quarterly revenue of $2.32 billion and a net profit of $374 million. Despite negative corporate insider sentiment with recent share sales, the overall analyst consensus for Equinix is a Strong Buy.

**4. Corient Private Wealth LLC Sells 3,281 Shares of BlackRock $BLK**
- Source: MarketBeat | 20251216T110801 | Neutral | Relevance: 63%
- Corient Private Wealth LLC reduced its stake in BlackRock (NYSE:BLK) by 3.0% in the second quarter, selling 3,281 shares and retaining 106,917 shares valued at $112.18 million. Despite missing quarterly EPS estimates, BlackRock exceeded revenue expectations with a 25.2% increase to $6.51 billion. Insider transactions included significant sales by Director Rachel Lord and CFO Martin Small, though corporate insiders still own nearly 2% of the stock.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 6 ($0.28M) |
| Sells | 6 ($6.97M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 9 / 0 |

**Top Holders:**
- Vanguard Group Inc: 16.0% (+0.4%)
- Blackrock Inc.: 10.7% (+1.4%)
- State Street Corpora: 5.8% (+1.9%)
- Cohen & Steers Inc.: 5.3% (+14.4%)
- Geode Capital Manage: 2.8% (+1.3%)

### Key Risks

1. Insider selling cluster: $7.0M in recent transactions.
2. Long-term trend broken: trading 16.5% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.08 suggests fair value with growth premium. Forward P/E 34.8x stretched relative to 11% growth. Quality metrics strong (ROE 225%). Insider selling cluster ($7.0M in 90 days), potential headwind. Institutional flow bullish (9 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $23.3B |
| Beta | 1.15 |
| 52W Range | $72.33 - $112.18 |
| Short Interest | 4.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.08 |
| Forward P/E | 34.8 |
| Current P/E | 38.6 |
| YoY Growth | 11.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -3.1% to -4.5% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.5pp (needs >4.0% for momentum thesis). AM_20 at -5.2% indicates price below own 20MA trend. Underperforming sector by 4.2pp, stock-specific weakness. Below SMA200 (0.83x), long-term trend not supportive. RSI oversold at 29, potential bounce setup. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.54% (CS: 12) | Weak |
| RSI_14 | 29.2 | Oversold |
| MACD Histogram | -0.03 | Bearish |
| vs SMA20 | 0.940x | Below |
| vs SMA50 | 0.838x | Below |
| vs SMA200 | 0.835x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $78.88
- **Stop Loss:** $72.56 (8.0% risk)
- **Target:** $91.52 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 150
- **Position Value:** $11,832.00
- **Portfolio %:** 11.83%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-12 (Est: $0.59)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.53 | $0.54 | +2.4% |
| 2025Q2 | $0.50 | $0.48 | -4.2% |
| 2025Q1 | $0.40 | $0.43 | +7.0% |
| 2024Q4 | $0.53 | $0.50 | -6.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*